Most of Aspreys acolytes arent likely to take things as far as he does, but even low-key biohacking has potential problems
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, et al
The review highlights data from randomized controlled trials and meta-analyses that demonstrate reductions in both apnea-hypopnea index (AHI) and body weight among patients treated with GLP-1RA and dual GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptor agonists
Tumor volume was lower but not statistically significant
Current research on BPC-157 is extensive in preclinical settings (studies not involving humans), where it has shown an impressive safety profile